Pnc Financial Services Group, Inc. Krystal Biotech, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 1,680 shares of KRYS stock, worth $251,865. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,680
Previous 1,644
2.19%
Holding current value
$251,865
Previous $298,000
11.74%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding KRYS
# of Institutions
309Shares Held
24.3MCall Options Held
483KPut Options Held
364K-
Black Rock Inc. New York, NY3.95MShares$592 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.88MShares$432 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.62MShares$393 Million7.18% of portfolio
-
State Street Corp Boston, MA1.45MShares$218 Million0.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$148 Million9.67% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $3.85B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...